Beiley Biofund Inc. (TPEX:7882)

Taiwan · Delayed Price · Currency is TWD

29.00

+5.05 (21.09%)

At close: Sep 7, 2026

Market Cap	6.16B
Revenue (ttm)	1.23B +773.3%
Net Income	1.13B +1,066.3%
EPS	5.29 +1,066.0%
Shares Out	212.47M
PE Ratio	5.48
Forward PE	n/a
Dividend	1.35 (6.16%)
Ex-Dividend Date	Sep 3, 2026

Volume	4,066,154
Open	23.95
Previous Close	23.95
Day's Range	23.95 - 29.80
52-Week Range	17.01 - 32.42
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Beiley Biofund

Beiley Biofund Inc. is a principal investment firm specializing in early stage investments. It prefers to invest in life sciences by partnering with innovators to develop breakthrough therapies and technologies. It typically invests in biotechnology and medical innovation. Beiley Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan. [Read more]

Industry Management Investment Offices, Open-End

Founded 2013

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 7882

Full Company Profile

Financial Performance

In 2025, Beiley Biofund's revenue was 1.23 billion, an increase of 773.27% compared to the previous year's 140.54 million. Earnings were 1.13 billion, an increase of 1066.28%.

Financial Statements